Skip to main content
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
2.820
-0.130 (-4.41%)
Oct 31, 2024, 4:00 PM EDT - Market closed

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $17.41M in the quarter ending June 30, 2024, a decrease of -9.71%. This brings the company's revenue in the last twelve months to $66.75M, down -63.80% year-over-year. In the year 2023, ADC Therapeutics had annual revenue of $69.56M, down -66.86%.

Revenue (ttm)
$66.75M
Revenue Growth
-63.80%
P/S Ratio
3.62
Revenue / Employee
$243,599
Employees
274
Market Cap
272.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020---
Dec 31, 20192.34M1.20M105.26%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 292.73M
Zynex 193.67M
Vanda Pharmaceuticals 182.02M
Sutro Biopharma 169.36M
uniQure 27.71M
Fate Therapeutics 12.32M
Immutep 2.56M
Revenue Rankings

ADCT News

More News